S. Diekamp

AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity

D. Reinhardt, J. Starý, U. Creutzig, 2005, Leukemia.

Gemtuzumab Ozogamicin (Mylotarg®) in Children with Refractory or Relapsed Acute Myeloid Leukemia

D. Reinhardt, C. Zwaan, H. Jürgens, 2004, Oncology Research and Treatment.

Acute Megakaryoblastic Leukemia in Children without Down’s Syndrome.

J. Harbott, D. Reinhardt, W. Ludwig, 2004 .

Transitorisch myeloproliferatives Syndrom bei Neugeborenen mit Down-Syndrom

U. Creutzig, S. Diekamp, D. Reinhardt, 2006, Monatsschrift Kinderheilkunde.

Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML

D. Reinhardt, U. Creutzig, M. Zimmermann, 2007, Pediatric blood & cancer.

Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment

J. Harbott, D. Reinhardt, W. Ludwig, 2005, Leukemia.